AHNTI EU Agenda (Workshops, Briefings, Roundtables) | Kisaco Research

AHNTI EU Agenda (Workshops, Briefings, Roundtables)

Agenda Days: 
  • Workshops & Roundtables: Monday, 2 Mar, 2026
    8:30am - 9:00am

    REGISTRATION FOR WORKSHOP & ROUNDTABLE ATTENDEES ONLY

    • By registering your interest to these sessions, you are agreeing for your information to be shared with the host.
    • The host of the workshop reserves the right to refuse entry to any organisation that they feel may be competitive.
    • You will receive confirmation of workshop registration via email prior to the event.
    Summary: 
    All Monday Workshops, Roundtables & Briefings require guests to 'register their interest' when registering for the main event.
    Session Type: 
    General Session (Presentation)
    9:00am - 10:30am
    Workshops

    WORKSHOP: Streamlined Pathways for Animal Health Innovation

    We will explore the full spectrum of market assessment, regulatory validation, and development planning required to bring innovative animal health products to market. We will examine how robust market analysis drives investor interest and attracts strategic corporate partners, while also serving as the foundation for confirming regulatory pathways and requirements.

    Building on this foundation, we will outline strategies and tactics for regulatory approval, the creation of targeted development plans, and approaches to expedite product positioning and launch.

    Additional insights will be shared on co-development opportunities with corporate animal health companies, offering participants a clear roadmap from concept to commercialization.

    Sponsor(s): 
    Paul Dick and Associates
    Speaker(s): 

    Author:

    Paul Dick

    President
    Paul Dick & Associates

    Dr Paul Dick D.V.M. M.Sc. obtained his veterinary medical degree with honours in 1984.

    While working in clinical practice he completed his Masters in Immunology and Virology transitioning into the Pharmaceutical industry in 1988. Dr. Dick has over 25 years experience in the pharmaceutical space including general management and leadership roles, business development, commercialization, regulatory affairs, and product development encompassing medicinal, non-medicinal and natural health products.

    His work in this sector has ranged from small “start up” companies to medium and large multi-nationals functioning in various capacities from research to COO and CEO.

    Dr. Dick has worked extensively with Health Canada and the Canadian Food Inspection Agency on numerous regulatory submissions and on several Departmental Committees.

    In addition he has been a recipient of the NSERC Synergy Award and has served as a peer reviewer of NSERC strategic grants. He is currently heading his own consulting firm ( Paul Dick and Associates Ltd.) and is the managing partner and president of a venture capital partnership (Vet Venture Capital Inc.).

    ... read more

    Paul Dick

    President
    Paul Dick & Associates

    Dr Paul Dick D.V.M. M.Sc. obtained his veterinary medical degree with honours in 1984.

    While working in clinical practice he completed his Masters in Immunology and Virology transitioning into the Pharmaceutical industry in 1988. Dr. Dick has over 25 years experience in the pharmaceutical space including general management and leadership roles, business development, commercialization, regulatory affairs, and product development encompassing medicinal, non-medicinal and natural health products.

    His work in this sector has ranged from small “start up” companies to medium and large multi-nationals functioning in various capacities from research to COO and CEO.

    Dr. Dick has worked extensively with Health Canada and the Canadian Food Inspection Agency on numerous regulatory submissions and on several Departmental Committees.

    In addition he has been a recipient of the NSERC Synergy Award and has served as a peer reviewer of NSERC strategic grants. He is currently heading his own consulting firm ( Paul Dick and Associates Ltd.) and is the managing partner and president of a venture capital partnership (Vet Venture Capital Inc.).

    Time: 
    9.00am - 10.30am
    Agenda Track No.: 
    Track 7
    Session Type: 
    General Session (Presentation)

    WORKSHOP

    Time: 
    9.00am - 10.30am
    Agenda Track No.: 
    Track 8
    Summary: 
    Details to be announced shortly
    Session Type: 
    General Session (Presentation)

    ROUNDTABLE: AI and Innovation - How companies are using AI to discover new technologies for livestock health

    Key discussions points

    • Predictive disease modelling and early detection
    • AI to support smarter vaccine development and deployment
    • Interpretation of complex biological data (omics)
    • Training LLMs to summarize complex topics and specialized literature
    • Current AI-based tools for patent search and discovery
    Sponsor(s): 
    United Animal Health
    Speaker(s): 

    Author:

    Sebastiano Busato

    Associate Research Scientist
    United Animal Health
    ... read more

    Sebastiano Busato

    Associate Research Scientist
    United Animal Health

    Author:

    Nathan Horn

    Scientific Discovery Lead
    United Animal Health
    ... read more

    Nathan Horn

    Scientific Discovery Lead
    United Animal Health
    Time: 
    9.30am-10.30am
    Agenda Track No.: 
    Track 9
    Session Type: 
    General Session (Presentation)
    10:45am - 12:15pm
    Workshops

    WORKSHOP: Go-to-Market Greatness - Defining Excellence and the Power of Partnership

    Partnerships are critical to commercialisation journeys within the animal health market. In this session we will discuss how to evaluate the right partner for your go-to-market strategy and identify the right time to engage in that relationship.

    Key takeaways will include:

    • Drivers of successful partnerships and the realisation of value
    • Factors to consider when evaluating and planning route to market
    Sponsor(s): 
    Circa Healthcare
    Speaker(s): 

    Author:

    Karin Jager

    President
    Circa Healthcare
    ... read more

    Karin Jager

    President
    Circa Healthcare
    Time: 
    10.45am - 12.15pm
    Agenda Track No.: 
    Track 7
    Session Type: 
    General Session (Presentation)

    WORKSHOP

    Sponsor(s): 
    MSD Animal Health
    Time: 
    10.45am - 12.15pm
    Agenda Track No.: 
    Track 8
    Summary: 
    Details to be announced shortly
    Session Type: 
    General Session (Presentation)
    12:30pm - 2:00pm
    Workshops

    WORKSHOP

    Time: 
    12.30pm - 2.00pm
    Agenda Track No.: 
    Track 7
    Summary: 
    Details to be announced shortly
    Session Type: 
    General Session (Presentation)

    WORKSHOP: Animal Health in the Next 5 Years: AI (Artificial Intelligence) & Digital Transformation (Companion + Livestock)

    Animal health is moving from occasional clinic visits to connected, everyday care.

    For COMPANION animals, AI (Artificial Intelligence) will sit quietly in the background-helping veterinarians read images, draft notes, and turn wearable and home-test data into simple, personal care plans. That means earlier flags for osteoarthritis, weight issues, heart or kidney changes, and skin flares, with clearer next steps for pet parents.

    For LIVESTOCK, Precision Livestock Farming (PLF) brings tags, cameras, and barn sensors together to spot lameness, mastitis, respiratory disease, heat stress, and calving risks before they spread-while also guiding feed and welfare.

    On the BUSINESS side, digital tools unlock practical wins: condition-based subscriptions and adherence programs, outcome-based agreements with producers and insurers, and “copilot” automations that trim busywork in pharmacovigilance (PV), medical information (MI), R&D; (research and development), and supply chain.

    We’ll separate hype from helpful, share a short list of metrics that matter, and finish with a 90-day starter plan so you leave with two pilot ideas you can launch within the next 30 days.

    Sponsor(s): 
    AskVet
    Speaker(s): 

    Author:

    Cal Lai

    Chairman & CEO
    Ask.vet



    ... read more

    Cal Lai

    Chairman & CEO
    Ask.vet



    Time: 
    12.30pm - 2.00pm
    Agenda Track No.: 
    Track 8
    Session Type: 
    General Session (Presentation)

    ROUNDTABLE

    Time: 
    12.30pm - 1.30pm
    Agenda Track No.: 
    Track 9
    Summary: 
    Details to be announced shortly
    Session Type: 
    General Session (Presentation)
    12:00pm
    12:40pm - 3:55pm
  • Briefings: Monday, 2 Mar, 2026
    9:45am - 10:15am

    REGISTRATION FOR BRIEFING ATTENDEE ONLY

    • By registering your interest to these sessions, you are agreeing for your information to be shared with the host.
    • The host of the workshop reserves the right to refuse entry to any organisation that they feel may be competitive.
    • You will receive confirmation of workshop registration via email prior to the event.
    Session Type: 
    General Session (Presentation)
    10.15am - 12.30pm

    Investor Briefing Part I: State of the Industry - Factors fuelling growth and deal flow

    Industry partners most heavily involved in transactions across the ecosystem will share a data driven view of the market and discuss activity over the last 5 years and what we can expect in the next 5.

    Speaker(s): 
    Moderator

    Author:

    Robert Darwin

    Partner
    Sidley Austin LLP
    ... read more

    Robert Darwin

    Partner
    Sidley Austin LLP
    Time: 
    10.15am - 11.15am
    Agenda Track No.: 
    Track 11
    Summary: 
    For Investors Only
    Session Type: 
    General Session (Presentation)

    Investor Briefing Part II: Navigating Opportunities in Animal Health: Biopharma, Nutrition, Diagnostics and Technology

    Our panel of experienced animal health investors and deal makers will discuss their investment thesis, commercialisation and exit strategies.

    Speaker(s): 
    Panellists

    Author:

    Spencer Swayze

    Managing Director
    Osiris Growth Capital
    ... read more

    Spencer Swayze

    Managing Director
    Osiris Growth Capital

    Author:

    Dave Ross

    Partner
    Agrifood Investment Advisory LLP
    ... read more

    Dave Ross

    Partner
    Agrifood Investment Advisory LLP

    Author:

    Wendy Furness

    Director & Founder
    Animal Health Angels
    ... read more

    Wendy Furness

    Director & Founder
    Animal Health Angels

    Author:

    Julia Stephanus

    Partner
    Borealis Ventures

    Julia has been a visionary entrepreneur and strategic brand builder in the veterinary industry for 30+ years. Her achievements include building and scaling two successful start-up veterinary pharmaceutical businesses and launching 28 veterinary products.  She was Founder and CEO of Summit VetPharm, which exited to Ceva Animal Health in 2010.  As Chief Commercial Officer of Aratana Therapeutics (PETX), she was instrumental in the IPO and the buildout of a fully integrated commercial organization.  Julia led the co-promotion and the licensing of Aratana’s lead osteoarthritis product, Galliprant®, to Elanco.  Aratana exited to Elanco in 2019.

    Julia is Founder and President of Avviare, LLC, providing consulting services to start-ups and established players in veterinary biopharmaceuticals.  In addition to the start-up experience, Julia’s career includes senior-level positions at Ceva, Forest Laboratories (Allergan) and Pfizer Animal Health (Zoetis) and their legacy companies.

    Julia presently serves on the Boards of PBI Gordon, ReduxBio, and Jenga Biosciences.  Julia is a Founding Director and Board Member of Feather in Her Cap, recognizing outstanding women in Animal Health.  

    Julia received her Bachelor of Arts from Indiana University in Bloomington, Indiana, with additional education at the Wharton School of Business, Columbia University, the University of Chicago, and Harvard University.

    ... read more

    Julia Stephanus

    Partner
    Borealis Ventures

    Julia has been a visionary entrepreneur and strategic brand builder in the veterinary industry for 30+ years. Her achievements include building and scaling two successful start-up veterinary pharmaceutical businesses and launching 28 veterinary products.  She was Founder and CEO of Summit VetPharm, which exited to Ceva Animal Health in 2010.  As Chief Commercial Officer of Aratana Therapeutics (PETX), she was instrumental in the IPO and the buildout of a fully integrated commercial organization.  Julia led the co-promotion and the licensing of Aratana’s lead osteoarthritis product, Galliprant®, to Elanco.  Aratana exited to Elanco in 2019.

    Julia is Founder and President of Avviare, LLC, providing consulting services to start-ups and established players in veterinary biopharmaceuticals.  In addition to the start-up experience, Julia’s career includes senior-level positions at Ceva, Forest Laboratories (Allergan) and Pfizer Animal Health (Zoetis) and their legacy companies.

    Julia presently serves on the Boards of PBI Gordon, ReduxBio, and Jenga Biosciences.  Julia is a Founding Director and Board Member of Feather in Her Cap, recognizing outstanding women in Animal Health.  

    Julia received her Bachelor of Arts from Indiana University in Bloomington, Indiana, with additional education at the Wharton School of Business, Columbia University, the University of Chicago, and Harvard University.

    Time: 
    11.30am - 12.30pm
    Agenda Track No.: 
    Track 11
    Summary: 
    For Investors Only
    Session Type: 
    General Session (Presentation)

    Practice Group AI & Data Briefing Part I: R&D Collaborations

    Speaker(s): 

    Author:

    Dan O'Neil

    Associate Professor in Companion Animal Epidemiology
    Royal Veterinary College, University of London
    ... read more

    Dan O'Neil

    Associate Professor in Companion Animal Epidemiology
    Royal Veterinary College, University of London

    Author:

    David Singleton

    Director of Research
    IVC Evidensia
    ... read more

    David Singleton

    Director of Research
    IVC Evidensia
    Time: 
    10.15am - 11.15am
    Agenda Track No.: 
    Track 12
    Session Type: 
    General Session (Presentation)

Jump to: Monday, 2 Mar | Monday, 2 Mar

Agenda Tracks: 
Track Title: 
1-2-1 Meetings
Track Color: 
#46dacc
Track Title: 
Next Stage One
Track Color: 
#6ce430
Track Title: 
Next Stage Two
Track Color: 
#dd1dae
Track Title: 
Changemaker A
Track Color: 
#d9dbcf
Track Title: 
Changemaker B
Track Color: 
#95a1a0
Track Title: 
Changemaker C
Track Color: 
#585d5e
Track Title: 
Workshop Stream A
Track Description: 
30 Seat Capacity
Track Color: 
#c1c3b6
Track Title: 
Workshop Stream B
Track Description: 
30 Seat Capacity
Track Color: 
#807676
Track Title: 
Roundtable Stream A
Track Description: 
10 Seat Capacity
Track Color: 
#eccaca
Track Title: 
Roundtable Stream B
Track Description: 
10 Seat Capacity
Track Color: 
#e49d9d
Track Title: 
Investor Briefing
Track Color: 
#1a54c3
Track Title: 
Practice Group Briefing
Track Color: 
#ecdc15
Event Reference: 
AHNTI EU 2026